Analysis of growth factor signaling in genetically diverse breast cancer lines

Mario Niepel, Marc Hafner, Emily A Pace

  • 1HMS LINCS Center, Department of Systems Biology, Harvard Medical School, 200 Longwood Ave, WAB 444, Boston, MA 02115, USA. bschoeberl@merrimackpharma.com.

BMC Biology
|March 25, 2014
PubMed
Abstract

Insights

Breast cancer cell signaling is highly diverse, with triple-negative breast cancers showing broad responsiveness to growth factors. This variability impacts tumor development and treatment strategies.

Area of Science:

  • Cancer Biology
  • Molecular Signaling
  • Genomics

Background:

  • Soluble growth factors in the tumor microenvironment are critical for cancer progression and therapy response.
  • Existing research on growth factor signaling pathways is limited in scope across diverse cancer cell types.

Purpose of the Study:

  • To create a quantitative, comparative dataset of immediate-early signaling in breast cancer.
  • To analyze AKT and ERK pathway activation across genetically diverse breast cancer cell lines.

Main Methods:

  • Quantitative analysis of AKT (AKT1/2/3) and ERK (MAPK1/3) pathway signaling.
  • Comparative study across a panel of well-characterized breast cancer cell lines.
  • Development of interactive web-based tools for data analysis.

Main Results:

  • Breast cancers exhibit significant diversity in ligand sensitivity and signaling biochemistry.
  • Triple-negative breast cancers (TNBCs) are broadly responsive to growth factors; HER2-amplified cancers are least responsive.
  • The ERK/AKT activation ratio varies by ligand and subtype, with a bias towards ERK in hormone receptor-positive (HR+) cells.

Conclusions:

  • Growth factor responses are highly diverse even within breast cancer subtypes.
  • Diversity is attributed to receptor abundance, ligand-dependent ERK/AKT bias, cell-line specific factors, and ErbB2-mediated negative regulation.
  • This work provides a foundation for predictive models of growth factor signaling in cancer.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
7.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K